tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nano-X Imaging Reports Q3 2025 Results and Strategic Advances

Story Highlights
  • Nano-X Imaging reported Q3 2025 revenue of $3.4 million, up from $3.0 million in 2024.
  • The company acquired Vaso Healthcare IT and secured collaborations to boost global commercialization.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nano-X Imaging Reports Q3 2025 Results and Strategic Advances

TipRanks Black Friday Sale

An announcement from Nano-X Imaging ( (NNOX) ) is now available.

On November 20, 2025, Nano-X Imaging Ltd announced its financial results for the third quarter ending September 30, 2025, reporting a revenue increase to $3.4 million from $3.0 million in the same period in 2024. The company highlighted strategic advancements, including acquiring Vaso Healthcare IT and securing new commercial collaborations to accelerate the global commercialization of its Nanox.ARC and AI solutions. Despite a net loss of $13.7 million, Nano-X continues to focus on expanding its market presence and improving operational efficiency, with plans to deploy over 100 units worldwide by the end of 2025.

The most recent analyst rating on (NNOX) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Nano-X Imaging stock, see the NNOX Stock Forecast page.

Spark’s Take on NNOX Stock

According to Spark, TipRanks’ AI Analyst, NNOX is a Neutral.

Nano-X Imaging’s overall stock score is driven by financial challenges and a bearish technical outlook. While there are positive developments in installations and partnerships, the company’s ongoing losses and unattractive valuation weigh heavily on the score. The strong equity position and potential for short-term technical rebounds offer some hope, but significant strategic improvements are needed for long-term sustainability.

To see Spark’s full report on NNOX stock, click here.

More about Nano-X Imaging

Nano-X Imaging Ltd is an innovative medical imaging technology company focused on advancing medical imaging solutions. The company is engaged in the commercialization of its Nanox.ARC and AI solutions, with a market focus on expanding its presence globally, including significant inroads into the European market.

Average Trading Volume: 1,251,209

Technical Sentiment Signal: Sell

Current Market Cap: $193.2M

For a thorough assessment of NNOX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1